Table 5. Survival analysis of multivariate COX hazard model based on TIMER online tool.
Clinicopathologic variable | Coef | 95% CI | HR | P-value |
Age | 0.016 | 1.00−1.03 | 1.02 | 0.068 |
Gender Male | −0.019 | 0.61−1.59 | 0.98 | 0.938 |
Race Black | 1.201 | 1.20−9.21 | 3.32 | 0.021 |
Race White | −0.002 | 0.60−1.66 | 1.00 | 0.995 |
Stage II | 0.081 | 0.63−1.87 | 1.09 | 0.770 |
Stage III | 0.748 | 1.30−3.43 | 2.11 | 0.003 |
Stage IV | 1.522 | 1.31−15.99 | 4.58 | 0.017 |
Purity | 0.419 | 0.47−4.95 | 1.52 | 0.487 |
B cell | −7.514 | 0.00−0.84 | 0.00 | 0.045 |
CD8 T cell | −5.056 | 0.00−0.92 | 0.01 | 0.046 |
CD4 T cell | −9.241 | 0.00−0.18 | 0.00 | 0.016 |
Macrophage | 8.546 | 18.24−1452349.07 | 5146.34 | 0.003 |
Neutrophil | −5.479 | 0.00−478.27 | 0.00 | 0.357 |
Dendritic | 4.945 | 3.02−6526.97 | 140.42 | 0.012 |
CENPL | 0.389 | 1.11−1.96 | 1.48 | 0.007 |
Abbreviations: TIMER: Tumor Immune Estimation Resource; CENPL: centromere protein L; HR: hazard ratio; Coef: coefficient.